Evidence map›Paper›PMID 41599112›Full record

ArticlePharmaceutics2025

Evaluation of Lipid Nanoparticles as Vehicles for Optogenetic Delivery in Primary Cortical Neurons.

José David Celdrán, Lawrence Humphreys, Maria Jose Verdú, Desirée González, Cristina Soto-Sánchez, Gema Martínez-Navarrete, Lucía Enríquez, Iván Maldonado, Idoia Gallego, Mohamed Mashal and 4 more

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

José David CeldránBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.ORCID 0000-0001-5058-9755
Lawrence HumphreysBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.ORCID 0000-0003-1366-1396
Maria Jose VerdúBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.
Desirée GonzálezBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.
Cristina Soto-SánchezBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.ORCID 0000-0003-4447-5967
Gema Martínez-NavarreteBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.ORCID 0000-0002-9795-2846
Lucía EnríquezNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-9072-5245
Iván MaldonadoNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-4119-8514
Idoia GallegoNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-9312-8147
Mohamed MashalNanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0001-5373-7178
Noha AttiaNanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0002-2618-3891
Gustavo PurasNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-1536-7601
José Luis PedrazNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-3938-2267
Eduardo FernándezBiomedical Neuroengineering, Institute of Bioengineering (IB), University Miguel Hernández (UMH), 03020 Elche, Spain.ORCID 0000-0002-7052-6011

Funding

Horizon 2020 No. 899287 (NeuraViPeR)Ministerio de Ciencia, Innovación y Universidades DTS19/00175Ministerio de Ciencia, Innovación y Universidades PDC2022-133952-100Ministerio de Ciencia, Innovación y Universidades PID2019-106199RB-C21Ministerio de Ciencia, Innovación y Universidades PRE2019-087693Ministerio de Ciencia, Innovación y Universidades PRE 202210042Ministerio de Ciencia, Innovación y Universidades RTI2018-098969-B-I00
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

lipid nanoparticleslipofectamineneuron deliveryoptogenetics

Identifiers

PMID41599112
PMCPMC12845084

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.